News
Why US-EU trade deal faces jeopardy over ambiguous pharmaceutical tariffs
Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement . Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC report.
Stellantis said on Tuesday it faced greater headwinds this year including a 1.5-billion-euro impact from U.S. tariffs for ...
U.S. President Donald Trump and European Commission President Ursula von der Leyen have announced a sweeping trade deal ...
US President Donald Trump announced on Sunday that the United States was imposing 15-percent tariffs on all European Union ...
Dutch healthcare technology company Philips slashed its estimated tariff impact on Tuesday after the United States and the ...
2h
Part of the agreement involves a commitment to buy American oil and gas. Over the course of the Russia-Ukraine war, now in ...
The 15% tariff would be lower than previously threatened, but it would remain a high duty on America’s largest trading ...
Jeep owner Stellantis said on Monday it suffered a massive loss in the first half of the year, when it felt the first impact ...
Dutch medical equipment manufacturer Philips said Tuesday that the impact of US tariffs would be much less than it initially ...
A threatened 30% tariff on European wines would hurt many U.S. companies while hiking prices at home and in restaurants, ...
Royal Philips NV increased its profitability outlook as the impact of the trade war was not as severe as it feared.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback